At the Healthcare Analytics Summit™ 2024 (HAS® 24), Jennifer Doudna, PhD, of the University of California, Berkeley, sat down with Melissa Welch, MD, MPH, President of Welch Perspectives Healthcare ...

Scribe Therapeutics, Inc. (Scribe), a biotechnology company engineering purpose-built CRISPR technologies to reshape the treatment of disease by enabling earlier intervention, improved outcomes, and ...

A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics ...

Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...

Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...

CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...

Cas12a2, an RNA-triggered system that selectively kills cancer and virus-infected cells by inducing extensive DNA damage ...

SAN DIEGO & BRISBANE, Calif.--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, ...

The U.S. Patent and Trademark Office issued Caribou Biosciences, a startup co-founded by UC Berkeley researcher Jennifer Doudna, intellectual property rights for developments in CRISPR gene-editing ...

DUBLIN--(BUSINESS WIRE)--The "CRISPR Technology Market" report has been added to ResearchAndMarkets.com's offering. The CRISPR Technology Market was valued at USD 2024 in 2029, and is expected to ...